SB

Sundaramurthy Balasubramanian

Active Director Director DIN 08655681
DIN 08655681 First appointment Dec 2019 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Sundaramurthy Balasubramanian

Data last updated:

Sundaramurthy Balasubramanian is a Director at Rg Biozymes Private Limited (since 2019). The company operates in Research & Development.

DIN 08655681
Primary Designation Director
Industry Research & Development
First Appointment 31 Dec 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rg Biozymes Private Limited U73100TN2019PTC133560
Director31 Dec 20192019Active

Board colleagues of Sundaramurthy Balasubramanian

Directorship timeline

Open interactive timeline →
Rg Biozymes Private Limited
Premium access

Shareholding and investment profile for Sundaramurthy Balasubramanian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sundaramurthy Balasubramanian

Sundaramurthy Balasubramanian currently holds 1 directorship: Rg Biozymes Private Limited (Director, since 31 Dec 2019).

Sundaramurthy Balasubramanian was first appointed on 31 Dec 2019 as Director at Rg Biozymes Private Limited.

The current boards of Sundaramurthy Balasubramanian's companies include Baalasubramanian Nagalakshmi (Rg Biozymes Private Limited), Balasubramanian Ramprashanth (Rg Biozymes Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available